<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To evaluate the safety and efficacy of urgent carotid artery stenting (CAS) with technical modifications in patients with recent (&lt;24 hours) initial or recurrent (â‰¥2 episodes in 24 hours) <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) or with minor <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A single-center, prospective, observational study was begun in March 2005 to assess an urgent CAS protocol for the treatment of selected high-risk patients with <z:e sem="disease" ids="C0007273" disease_type="Disease or Syndrome" abbrv="">carotid artery disease</z:e> who presented within 24 hours of an initial or recurrent <z:hpo ids='HP_0002326'>TIA</z:hpo> or minor <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Up to June 2011, 78 patients (59 men; mean age 76 years) with <z:hpo ids='HP_0002326'>TIA</z:hpo> (n=57) or minor <z:hpo ids='HP_0001297'>stroke</z:hpo> (n=21) underwent urgent CAS (within 48 hours) for severe internal carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Outcome measures were major adverse cardiac and cerebrovascular events (MACCE), modifications in the National Institutes of Health <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (NIHSS) values for minor <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, and postoperative <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> rates </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Technical and procedural success rates were 100% and 97.4%, respectively; 1 intraoperative minor <z:hpo ids='HP_0001297'>stroke</z:hpo> occurred due to stent <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>At 30 days, 2 patients had recurrent minor <z:hpo ids='HP_0001297'>stroke</z:hpo>; one subsequently died after a hemorrhagic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The MACCE rate was 3.8% </plain></SENT>
<SENT sid="7" pm="."><plain>There were no cases of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> or access-related complications </plain></SENT>
<SENT sid="8" pm="."><plain>Of the 20 surviving minor <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, 14 showed improvement in neurological deficit on the NIHSS scale at 30 days, while 5 remained stable and one was neurologically impaired </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Urgent CAS in selected patients with symptomatic <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> was satisfactory in preventing the recurrence of <z:hpo ids='HP_0002326'>TIA</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> in this study </plain></SENT>
<SENT sid="10" pm="."><plain>Urgent CAS with careful patient selection, contemporary tools (medical and technical), and expert technique may represent a possible solution for some patients with recent or recurrent <z:hpo ids='HP_0002326'>TIA</z:hpo> or minor <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>